Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.
about
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeAPOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriersAlzheimer's Genetic Risk Intensifies Neurocognitive Slowing Associated with Diabetes in Non-Demented Older AdultsGenetic factors moderate everyday physical activity effects on executive functions in aging: Evidence from the Victoria Longitudinal Study.Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.Interaction Effects of BDNF and COMT Genes on Resting-State Brain Activity and Working Memory.Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study.Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review
P2860
Q26752744-E0283580-BCAD-4D17-9DD2-275C1271BF9EQ34139700-F72EF83D-2447-488A-A51B-0E4D6806B4C9Q35572281-570AE13C-ADB7-45DB-B905-58EF9506936FQ36350995-245B16FA-5C49-4C3A-88C8-6069FDF5F598Q36410416-E8C2E373-0FF7-42CA-BEB8-EC3CDDCA8462Q36782197-7DAFE2A5-847F-4239-944A-054DE11E4DA0Q36870616-683AD508-5127-4004-8798-E5D1BF87F25AQ37387504-3B79F8BA-6C1F-48E4-BD30-98910AC3A258Q40547409-FC27DB56-30B5-4719-B00E-9133C247D831Q47815420-0D462FBC-F7E4-4626-AF3B-D5C2FE76B40CQ51767293-9A65DB88-7F0A-45BA-BE61-A09E33782A63Q58549216-A6B51AE9-A3B7-4690-9757-922F004DAA0A
P2860
Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synergistic associations of ca ...... modified by apolipoprotein E.
@ast
Synergistic associations of ca ...... modified by apolipoprotein E.
@en
Synergistic associations of ca ...... modified by apolipoprotein E.
@nl
type
label
Synergistic associations of ca ...... modified by apolipoprotein E.
@ast
Synergistic associations of ca ...... modified by apolipoprotein E.
@en
Synergistic associations of ca ...... modified by apolipoprotein E.
@nl
prefLabel
Synergistic associations of ca ...... modified by apolipoprotein E.
@ast
Synergistic associations of ca ...... modified by apolipoprotein E.
@en
Synergistic associations of ca ...... modified by apolipoprotein E.
@nl
P2093
P2860
P1476
Synergistic associations of ca ...... modified by apolipoprotein E.
@en
P2093
David Vergote
David Westaway
Jack Jhamandas
Roger A Dixon
Shraddha Sapkota
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2014.06.020
P577
2014-06-20T00:00:00Z